Wed, March 7, 2012
Tue, March 6, 2012
[ Tue, Mar 06th 2012 ] - Market Wire
Verotoxin and E. coli 0157
Mon, March 5, 2012
[ Mon, Mar 05th 2012 ] - Market Wire
Sienna Gold Warrants Extended
[ Mon, Mar 05th 2012 ] - Market Wire
30 a.m. ET
Fri, March 2, 2012
Thu, March 1, 2012
Wed, February 29, 2012
Tue, February 28, 2012
[ Tue, Feb 28th 2012 ] - Market Wire
Alere to Acquire eScreen, Inc.
[ Tue, Feb 28th 2012 ] - Market Wire
ICON Acquires PriceSpective
Mon, February 27, 2012
Sat, February 25, 2012
Fri, February 24, 2012
[ Fri, Feb 24th 2012 ] - Market Wire
BrainStorm Featured on CNBC
Thu, February 23, 2012
[ Thu, Feb 23rd 2012 ] - Market Wire
00 am ET

Natus to Present at Upcoming Financial Conferences


//health-fitness.news-articles.net/content/2012/ .. o-present-at-upcoming-financial-conferences.html
Published in Health and Fitness on Wednesday, February 29th 2012 at 11:25 GMT by Market Wire   Print publication without navigation


SAN CARLOS, Calif.--([ ])--Natus Medical Incorporated (Nasdaq:BABY) today announced that the Company is scheduled to present at two upcoming financial conferences.

Jim Hawkins, Chief Executive Officer of the Company, will make a presentation at the Raymond James 33rd Annual Institutional Investors Conference. The conference is being held at the JW Marriott Grande Lakes in Orlando, Florida on March 5-7, 2012. Mr. Hawkins is scheduled to present on Monday, March 5 at 9:15 a.m. Eastern Time (6:15 a.m. PT). Attendance at the Raymond James 33rd Annual Institutional Investors Conference is by invitation only.

Mr. Hawkins and Steven J. Murphy, Vice President Finance and Chief Financial Officer of the Company, will attend the Roth Capital Partners 24th Annual OC Growth Stock Conference. The conference is being held at the Ritz-Carlton Hotel, Laguna Niguel, California on March 11-14, 2012. Mr. Hawkins is scheduled to make a presentation on Monday, March 12 at 10:00 a.m. Pacific Time (1:00 p.m. ET). Attendance at the Roth Capital Partners 24th Annual OC Growth Stock Conference is by invitation only.

Investors may listen to a live webcast and view a copy of the slide presentation online via the aInvestorsa section of the Companyas web site at [ http://investor.natus.com ]. The recorded webcasts will be accessible online for at least 30 days.

About Natus Medical

Natus is a leading provider of healthcare products used for the screening, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, and balance and mobility disorders. Product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories.

Additional information about Natus Medical can be found at [ www.natus.com ].


Publication Contributing Sources